Results 11 to 20 of about 147,766 (171)

Pathophysiology of Portal Hypertension and Esophageal Varices [PDF]

open access: yesInternational Journal of Hepatology, 2012
Esophageal varices are the major complication of portal hypertension. It is detected in about 50% of cirrhosis patients, and approximately 5–15% of cirrhosis patients show newly formed varices or worsening of varices each year.
Hitoshi Maruyama, Osamu Yokosuka
doaj   +2 more sources

Left Gastric Vein Width Is an Important Risk Factor for Exacerbation of Esophageal Varices Post Balloon-Occluded Retrograde Transvenous Obliteration for Gastric Varices in Cirrhotic Patients

open access: yesMedicina, 2022
Background and Objectives: Balloon-occluded retrograde transvenous obliteration (BRTO) could be currently one of the best therapies for patients with gastric varices.
Taku Mizutani   +9 more
doaj   +2 more sources

The Role of Endoscopic Ultrasound for Esophageal Varices

open access: yesDiagnostics, 2020
Esophageal varices are caused by the development of collateral circulation in the esophagus as a result of portal hypertension. It is important to administer appropriate preventive treatment because bleeding varices can be fatal.
Kazunori Nagashima   +11 more
doaj   +2 more sources

Non-invasive predictors of esophageal varices

open access: yesThe Saudi Journal of Gastroenterology, 2011
Background/Aim: Current guidelines recommend screening cirrhotic patients with an endoscopy to detect esophageal varices and to institute prophylactic measures in patients with large esophageal varices.
Jijo V Cherian   +4 more
doaj   +2 more sources

Evaluation of endoscopic secondary prophylaxis in children and adolescents with esophageal varices

open access: yesArquivos de Gastroenterologia
BACKGROUND Bleeding of esophageal varices is the main cause of morbidity and mortality in children and adults with portal hypertension and there are few studies involving secondary prophylaxis in children and adolescents.
Júlio Rocha PIMENTA   +5 more
doaj   +2 more sources

Development of Fundal Varices in Cirrhotic Patients after Eradication of Esophageal Varices [PDF]

open access: yesJournal of Rawalpindi Medical College, 2017
Background: To analyze the development of fundal varices in cirrhotic patients after eradication of esophageal varices Methods: In this observational study 150 patients of liver cirrhosis, with the history of upper gastrointestinal tract bleed and ...
Muhammad Ajmal
doaj   +2 more sources

Tissue inhibitor of matrix metalloprotinase-1 and collagen type IV in HCV-associated cirrhosis and grading of esophageal varices

open access: yesEgyptian Liver Journal
Background Esophageal varices are abnormally dilated submucosal veins of the esophagus which develop as a result of portal hypertension due to cirrhosis. Collagen type IV is upregulated with a 14-fold increase in cirrhosis.
Nasser Mohamed Abdalla   +4 more
doaj   +2 more sources

PLATELET COUNT SQUARED/SPLEEN DIAMETER-ASPARTATE AMINOTRANSFERASE RATIO: NON-INVASIVE METHOD TO PREDICT ESOPHAGEAL VARICES [PDF]

open access: yesArquivos de Gastroenterologia, 2017
BACKGROUND - Variceal bleeding has a high mortality among cirrhotics, and screening with endoscopy is indicated at the diagnosis of cirrhosis. Screening with endoscopy implies discomfort, risks and considerable costs.
Ângelo Zambam de MATTOS   +2 more
doaj   +2 more sources

Baveno VII Criteria for the Exclusion of Esophageal Varices in a Peruvian Population: Cross-Sectional Study

open access: yesRevista Colombiana de Gastroenterología
Introduction: Esophageal varices represent one of the main complications in patients with liver cirrhosis. The main objective was to determine the diagnostic performance of the new Baveno VII criteria to exclude the presence of esophageal varices in ...
Celide Campoverde Cueva   +5 more
doaj   +2 more sources

Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis

open access: yesHepatology, EarlyView., 2022
Diagram of the activation of the profibrotic and procontractile Janus kinase 2 (JAK2)/Ras homolog family member A/Rho‐kinase pathway and the inhibition of phosphorylated JAK2 by pacritinib to inhibit hepatic stellate cell activity. Abstract Background and Aims Janus kinase 2 (JAK2) signaling is increased in human and experimental liver fibrosis with ...
Sandra Torres   +21 more
wiley   +1 more source

Home - About - Disclaimer - Privacy